Legend Biotech Corp (LEGN) reported its second-quarter earnings for 2025, revealing a significant increase in revenue but a larger-than-expected loss per share. The company’s revenue reached 255.06 ...

Legend Biotech reported an EPS of -$0.05, missing the forecast slightly. Revenue was $272.33 million, below the expected $274.72 million. The stock rose 2.93% in pre-market trading, indicating ...

Good morning, everybody. We're waiting for the few final people to pop into the conference, and we'll get started in just a few seconds. Everybody has joined the conference. So Randy, good to go.

Legend Biotech Corp (LEGN) reported its third-quarter earnings for 2025, revealing a mixed performance that fell short of market expectations. The company posted an earnings per share (EPS) of -$0.05, ...